Back
Avidity Biosciences Stock Price Chart

Could BOXABL Be the Tesla of Housing?
Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.
Sell
47
RNA
Avidity Biosciences
Last Price:
$30.39
Seasonality Move:
21.18%
7 Day Trial
ALL ACCESS PASS
$
7

This $60K Foldable Home Is Shaking Up Real Estate
Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.-
The current trend is moderately bullish and RNA is experiencing selling pressure, which indicates risk of future bearish movement.
Avidity Biosciences Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 30.44 | Sell |
20-day SMA: | 30.11 | Buy |
50-day SMA: | 29.48 | Buy |
200-day SMA: | 36.45 | Sell |
8-day EMA: | 30.35 | Sell |
20-day EMA: | 29.94 | Buy |
50-day EMA: | 29.94 | Buy |
200-day EMA: | 32.22 | Sell |
Avidity Biosciences Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.34 | Buy |
Relative Strength Index (14 RSI): | 52.18 | Buy |
Chaikin Money Flow: | -757012 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (28.48 - 31.94) | Buy |
Bollinger Bands (100): | (27.86 - 32.58) | Buy |
Avidity Biosciences Technical Analysis
May 13 | May 14 | May 15 | May 16 | May 19 | May 20 | May 21 | May 22 | May 23 | May 27 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
13 | 14 | 15 | 16 | 19 | 20 | 21 | 22 | 23 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Avidity Biosciences Stock
Is Avidity Biosciences Stock a Buy?
-
Avidity Biosciences share price is 30.35 while RNA 8-day simple moving average is 30.44, which is a Sell signal.
-
The stock price of RNA is 30.35 while Avidity Biosciences 20-day SMA is 30.11, which makes it a Buy.
-
Avidity Biosciences 50-day simple moving average is 29.48 while RNA share price is 30.35, making it a Buy technically.
-
RNA stock price is 30.35 and Avidity Biosciences 200-day simple moving average is 36.45, creating a Sell signal.
RNA Technical Analysis vs Fundamental Analysis
Sell
47
Avidity Biosciences (RNA)
is a Sell
Is Avidity Biosciences a Buy or a Sell?
-
Avidity Biosciences stock is rated a SellThe current Avidity Biosciences [RNA] share price is $30.35. The Score for RNA is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
Avidity Biosciences Stock Info
Market Cap:
3.7B
Price in USD:
30.35
Share Volume:
1.2M
Avidity Biosciences 52-Week Range
52-Week High:
56.00
52-Week Low:
21.51
Sell
47
Avidity Biosciences (RNA)
is a Sell
Avidity Biosciences Share Price Forecast
-
What is the Avidity Biosciences stock price today?The Avidity Biosciences stock price is 30.35 USD today.
-
Will RNA stock go up or go down?Avidity Biosciences> share price is forecast to RISE/FALL based on technical indicators
-
Is Avidity Biosciences overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Avidity Biosciences is overvalued.
Is Avidity Biosciences Stock a Buy?
-
Avidity Biosciences share price is 30.35 while RNA 8-day exponential moving average is 30.35, which is a Sell signal.
-
The stock price of RNA is 30.35 while Avidity Biosciences 20-day EMA is 29.94, which makes it a Buy.
-
Avidity Biosciences 50-day exponential moving average is 29.94 while RNA share price is 30.35, making it a Buy technically.
-
RNA stock price is 30.35 and Avidity Biosciences 200-day simple moving average is 32.22, creating a Sell signal.
Fundamental Analysis of Avidity Biosciences
Is Avidity Biosciences a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.30 per share, a decrease next quarter of $0.13 per share, a decrease this year of $1.11 per share, and a decrease next year of $0.47 per share.
Technical Analysis of Avidity Biosciences
Should I short Avidity Biosciences stock?
-
RNA Moving Average Covergence Divergence (MACD) indicator is 0.34, suggesting Avidity Biosciences is a Buy
-
Avidity Biosciences Relative Strength Index (RSI) is 52.18, which suggest Avidity Biosciences is overbought
-
The Bollinger Bands (25) for Avidity Biosciences is (28.48 - 31.94), which suggest Avidity Biosciences is a Buy
-
The Bollinger Bands (100) for Avidity Biosciences is (27.86 - 32.58), which suggest Avidity Biosciences is a Buy
* Avidity Biosciences stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.